Literature DB >> 1451945

The fiftieth anniversary of hypoglycaemic sulphonamides. How did the mother compound work?

J C Henquin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1451945     DOI： 10.1007/bf00401417

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  43 in total

1.  Stimulation by carbutamide and tolbutamide of insulin release from rat pancreas in vitro.

Authors:  P R BOUMAN; J H GAARENSTROOM
Journal:  Metabolism       Date:  1961-12       Impact factor: 8.694

2.  Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration.

Authors:  E F PFEIFFER; M PFEIFFER; H DITSCHUNEIT; C S AHN
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

3.  Carbutamide and plasma insulin activity.

Authors:  C VON HOLT; L VON HOLT; J KRACHT; B KRONER; J KUHNAU
Journal:  Science       Date:  1957-04-19       Impact factor: 47.728

4.  [An effective peroral anti-diabetic drug (BZ 55)].

Authors:  F BERTRAM; E BENDFELDT; H OTTO
Journal:  Dtsch Med Wochenschr       Date:  1955-10-07       Impact factor: 0.628

5.  [A new blood-sugar reducing substance; preliminary data].

Authors:  J D ACHELIS; K HARDEBECK
Journal:  Dtsch Med Wochenschr       Date:  1955-10-07       Impact factor: 0.628

6.  Hypoglycemic action of sulfanilamido-cyclopropylthiazole in rabbits, and its reversal by alloxan.

Authors:  K K CHEN; R C ANDERSON; N MAZE
Journal:  Proc Soc Exp Biol Med       Date:  1946-11

7.  Membrane potential of beta-cells in pancreatic islets.

Authors:  H P Meissner; H Schmelz
Journal:  Pflugers Arch       Date:  1974       Impact factor: 3.657

8.  Clonidine inhibits ATP-sensitive K+ channels in mouse pancreatic beta-cells.

Authors:  T D Plant; J C Jonas; J C Henquin
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

9.  Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells.

Authors:  J C Henquin; H P Meissner
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

10.  Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells.

Authors:  G Trube; P Rorsman; T Ohno-Shosaku
Journal:  Pflugers Arch       Date:  1986-11       Impact factor: 3.657
View more
  21 in total

Review 1.  Molecular defects in insulin secretion in type-2 diabetes.

Authors:  Frances M Ashcroft; Patrik Rorsman
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 3.  Insulin secretagogues: who, what, when, and how?

Authors:  George Dailey
Journal:  Curr Diab Rep       Date:  2005-10       Impact factor: 4.810

4.  Antidiabetic sulphonylureas activate mitochondrial permeability transition in rat skeletal muscle.

Authors:  Jolanta Skalska; Grazyna Debska; Wolfram S Kunz; Adam Szewczyk
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

5.  Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level.

Authors:  C Alarcon; B Wicksteed; C J Rhodes
Journal:  Diabetologia       Date:  2006-10-20       Impact factor: 10.122

6.  Regulation by metformin of the hexose transport system in vascular endothelial and smooth muscle cells.

Authors:  S Sasson; N Gorowits; H G Joost; G L King; E Cerasi; N Kaiser
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

7.  Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis.

Authors:  Bianca Hemmingsen; Jeppe B Schroll; Jørn Wetterslev; Christian Gluud; Allan Vaag; David P Sonne; Lars H Lundstrøm; Thomas Almdal
Journal:  CMAJ Open       Date:  2014-07-22

Review 8.  Comparative tolerability of sulphonylureas in diabetes mellitus.

Authors:  A D Harrower
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

Review 9.  Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency.

Authors:  A D Harrower
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

10.  The stimulatory action of tolbutamide on Ca2+-dependent exocytosis in pancreatic beta cells is mediated by a 65-kDa mdr-like P-glycoprotein.

Authors:  S Barg; E Renström; P O Berggren; A Bertorello; K Bokvist; M Braun; L Eliasson; W E Holmes; M Köhler; P Rorsman; F Thévenod
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.